Substance Use Disorder Awareness and Education

Based on 2020 and earlier NSDUH data, this report contains findings on a wide variety of key substance use and mental health indicators in the United States.

These estimated costs of opioid use disorder and fatal opioid overdose and their per capita costs at the state level can assist federal and state decision makers in understanding the magnitude of opioid use disorder and fatal opioid overdose in their jurisdictions.

The official CDC page on research pertaining to polysubstance use during pregnancy, suggesting ways to help reduce substance exposure during pregnancy and improve the health of women and their children.

A fact sheet which outlines new strategies that can reduce the risks from polysubstance use.

A summary of a workshop from the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-Term) Initiative, discussing opioid use in the context of polysubstance use.

This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.

This research report provides information on the state of the science in the comorbidity of substance use disorders with mental illness and physical health conditions.

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

A Practice Guideline which includes treatment recommendations for patients with substance use disorders, as well as background information and a review of available evidence.

Online screenings from Mental Health America (MHA) to quickly and easily determine whether someone is experiencing symptoms of a mental health condition.